From discovery to personalized medicine

Published on 29/03/2016

Soluble biomarkers development in osteoarthritis

A review that summarizes current guidance on the use of biomarkers in OA in clinical trials and their utility at five stages, including preclinical development and phase 1 to phase 4 trials. It also presents all the available regulatory requirements.

 © Artialis - All rights reserved
Cookie Notice - Privacy Policy